ProQR Therapeutics N.V. (PRQR) PT Raised to $44 at Citi
Tweet
Share
E-mailGet Alerts PRQR Hot Sheet
Price: $2.09 -1.88%
Rating Summary:
13 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
13 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz raised the price target on ProQR Therapeutics N.V. (NASDAQ: PRQR) to $44.00 (from $33.00) while maintaining a Buy rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Ser Educacional SA (SEER3:BZ) PT Raised to R$23 at JPMorgan
- Petroreconcavo SA (RECV3:BZ) PT Lowered to R$12 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
